Correspondence 0001213900-25-023419 from PSYENCE BIOMEDICAL LTD. (PBM)
PSYENCE BIOMEDICAL LTD.
Date: March 13, 2025 · CIK: 0001985062 · Accession: 0001213900-25-023419
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-285542
Letter
Psyence Biomedical Ltd.
121 Richmond Street West
Penthouse Suite 1300
Toronto, Ontario M5H 2K1
March 13, 2025
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporate Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Re: Psyence Biomedical Ltd.
Registration Statement on Form F-3
Filed March 4, 2025
File No. 333-285542
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Psyence Biomedical Ltd. hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 4:30 p.m. Eastern Time on Friday, March 14, 2025, or as soon as thereafter practicable.
Very truly yours,
PSYENCE BIOMEDICAL LTD.
Show Raw Text
CORRESP 1 filename1.htm Psyence Biomedical Ltd. 121 Richmond Street West Penthouse Suite 1300 Toronto, Ontario M5H 2K1 March 13, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporate Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Re: Psyence Biomedical Ltd. Registration Statement on Form F-3 Filed March 4, 2025 File No. 333-285542 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Psyence Biomedical Ltd. hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 4:30 p.m. Eastern Time on Friday, March 14, 2025, or as soon as thereafter practicable. Very truly yours, PSYENCE BIOMEDICAL LTD. By: /s/ Neil Maresky Neil Maresky